CXCL10 and diabetic kidney disease: Our results suggest that DKD patients’ higher rate of cardiovascular events may result, in part, from upregulation of CXCL10 and CXCL8 by lnc-SLC15A1-1, but further research for validating the in vitro data in animals and clinical patients is still needed.